艾伯科技(02708.HK)預計中期由虧轉盈逾300萬元
格隆匯11月10日丨艾伯科技(02708.HK)發佈公吿,公司預計截至2021年9月30日止六個月錄得公司擁有人應占溢利為不少於人民幣300萬元(截至2020年9月30日止六個月公司擁有人應占虧損為人民幣約1,545萬元),主要由於以下原因所致:在智能終端產品銷售的收入大幅增加帶動下,報吿期間的收入及毛利比2020年同期錄得可觀升幅;報吿期間可換股債券公平值變動錄得收益,而2020年同期可換股債券公平值變動則錄得虧損;及報吿期間應付代價公平值變動錄得收益,而2020年同期應付代價公平值變動則錄得虧損。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.